Stem Cell Company Executives, Scientists and Investors Will Gather Feb. 17
in New York City to Discuss Commercialization of Stem Cell Products
PHILADELPHIA, Aug. 12 /PRNewswire/ -- RRY Publications today announced the preliminary lineup of presenters for the 4th Annual Stem Cell Summit, the premier gathering of stem cell company executives, scientists and investors to focus on the commercialization of stem cell products. The Stem Cell Summit is an intensive one-day event that allows attendees to explore the therapeutic applications of stem cells, the successful path to stem cell product commercialization, and the latest investment opportunities within this marketplace.
The 4th Annual Stem Cell Summit features 35 corporate presenters,
keynote speaker Dr. Arnold Caplan, Ph.D., and a scientific panel
discussion. It will take place on February 17, 2009, at Bridgewaters in the
heart of New York City's historic South Street Seaport.
Confirmed presenting stem cell companies include:
3DM, Inc. Incell Corporation, LLC
Aastrom Biosciences, Inc. MaxCyte, Inc.
Aldagen, Inc. Moraga Biotechnology Corporation
AllCells, LLC Neuronyx, Inc.
Arteriocyte, Inc. Novocell, Inc.
BioE Corp. NuVasive, Inc.
California Stem Cell, Inc. Osiris Therapeutics, Inc.
Cellerix, S.A. Progenitor Cell Therapy, Inc.
Cognate BioServices, Inc. Stemagen
Cytori Therapeutics, Inc. Stemina, Inc.
Gamida Cell Ltd. TiGenix NV
Geron Corp. Tissue Genesis, Inc.
Harvest Technologies Corp. Vet-Stem, Inc.
In addition to the company and product overviews, Robin R. Young, CFA, the leading medical technologies analyst in the United States with over 25 years' experience in the cardiovascular, orthopedic and biomaterials industries and the award-winning president and organizer of the annual Stem Cell Summit, will deliver his updated 10-year market forecast for the industry.
"2008 has already been a record-breaking year for stem cell
technologies with two of the largest purchase contracts ever recorded - one
for more than $200 million from the U.S. government and another for $85
million to purchase a single stem cell product line," said Robin Young.
"There is little doubt that 2009 will be the year that stem cell companies
and technologies cross the $100 million in annual revenues line and become
a billion-dollar valuation industry."
4th Annual Stem Cell Summit Facts at a Glance
What: 2009's Premier Gathering of Stem Cell Company Executives,
Scientists and Investors
When: February 17, 2009
11 Fulton Street
New York City
Who: The Stem Cell Summit is organized by Robin R. Young, CFA and RRY
Admission: $950 early bird registration by November 30, 2008
$1,200 advance registration (December 1, 2008 - January 31,
$1,500 (February 1 - 17, 2009)
Information: For more information on presentation or sponsorship
opportunities, call Lisa Carpenter at 877-817-6450 or send an
email to email@example.com . Additional information, including
attendee registration details, is available at
Contacts: Lisa Carpenter
RRY Publications, LLC
|SOURCE RRY Publications|
Copyright©2008 PR Newswire.
All rights reserved